JEFFREY ALEXANDER FEINSTEIN M.D. NPI 1609867241

NPI Details

Jeffrey Alexander Feinstein, M.D. is a rheumatology internal medicine in Windcrest, TX with 28 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Jeffrey Alexander Feinstein, M.D. NPI is 1609867241. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8930 FOURWINDS DR STE 100
WINDCREST, TX
ZIP 78239-971
Phone: (210) 590-9596
Fax: (210) 590-6227

The NPI 1609867241 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg (HCPCS:J7318)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0221)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Vitamin d-3 level (HCPCS:82306)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection into tendon or ligament (HCPCS:20550)

The enumeration date for this NPI number is 11/2/2005 and was last updated on 12/4/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: